Substance Use Disorder

A coalition of 240 organizations came together to urge Congress to pass legislation to fight the opioid crisis.

Chronic adolescent exposure to THC and cannabis could lead to adverse mental health outcomes and impacted brain functioning.

How can psychiatrists improve substance use treatment for Black and pediatric patients?

At the Annual Psychiatric Times World CME Conference, an all-star lineup of presenters will share their latest research. Check out this preview of the full agenda.

The American Medical Association is urging policymakers to act now to prevent further opioid overdose deaths.

A vaccine that prevents oxycodone from entering the brain? This might be the safe, long-lasting, cost-effective solution for opioid use disorders.

What can be done to help patients turn painful memories into opportunities for posttraumatic growth?

Are benzodiazepine prescriptions contributing to the opioid overdose epidemic?

In this journal club, a medical student and an addiction psychiatrist review a thematic analysis of successful prevention efforts in states with declining rates of opioid-related overdose deaths.

A patient presents with multiple substance use disorders super-imposed on mood and anxiety disorders. Where does a clinician even begin?

Manufactured fentanyl is a major cause of overdoses for opioids and nonopiods. Can a vaccine immunize against overdose?

After the largest increase in overdose deaths in 50 years, the American Psychiatric Association sends out the call for improved substance use care.

Novel digital therapy modia will be evaluated in combination with sublingual buprenorphine/naloxone background therapy to see whether it is superior in reducing opioid use.

Yes, we need better crisis management, but what we really need is better crisis prevention.

Adial’s AD04 for the treatment of alcohol use disorder received a Notice of Allowance from the US Patent and Trademark Office.

The Drug Policy Reform Act, introduced today, intends to decriminalize drug use and possession, providing health-centered approaches and rehabilitation instead.

How can understanding the opioid crisis in Canada inform strategies in the United States?

Healthy lungs are at risk—what can you do as a clinician to help patients quit vaping?

How can mental health professionals promote a true community of immunity?

As all eyes were on the pandemic, another surge simmered below the surface.

The COVID-19 pandemic has exacerbated mental health and gender inequalities around the world. Understanding the causes is the first step toward finding solutions.

According to Nora D. Volkow, MD, Director of the National Institute on Drug Abuse, drug use and overdose deaths have significantly increased since the outset of the pandemic. What made it worse?

The Drug Enforcement Administration has freed this formerly schedule II controlled substance.

Looking to reduce youth initiation into tobacco products, the FDA takes steps against menthol cigarettes and flavored cigars.

Government funding for the drug addiction crisis is on the way.

The sharply decreasing perception of risk and easy accessibility of cannabis has many patients turning towards it, despite the potential negative effects.

The rapidly changing field of cannabinoids and their clinical implications poses a particular challenge in psychiatry.

A synthesis of quantitative reviews on the relationship between cannabis use and psychosis.